Cart
sales@molnova.com
AMG319
CAS No. 1608125-21-8
AMG319( AMG-319 | AMG 319 )
Catalog No. M12313 CAS No. 1608125-21-8
AMG319 (AMG-319) is a potent and selective PI3Kδ inhibitor with biochemical IC50 of 18 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 70 | In Stock |
|
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 227 | In Stock |
|
| 50MG | 380 | In Stock |
|
| 100MG | 554 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAMG319
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMG319 (AMG-319) is a potent and selective PI3Kδ inhibitor with biochemical IC50 of 18 nM.
-
DescriptionAMG319 (AMG-319) is a potent and selective PI3Kδ inhibitor with biochemical IC50 of 18 nM, displays >80-fold selectivity over PI3Kα/β/γ (IC50=3300/2700/850 nM); exhibits an IC50 of 16 nM in human whole blood assay (HWB), excellent selectivity over a large panel of protein kinases; inhibits anti-IgM induced AKT phosphorylation (Ser473) in mouse B cells with IC50 of 1.5 nM, inhibits anti-IgM/CD40L-induced B cell proliferation with IC50 of 8.6 nM; exhibits in vivo efficacy in rodent disease models of inflammation.Solid Tumors Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsAMG-319 | AMG 319
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kα|PI3Kβ|PI3Kγ|PI3Kδ
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number1608125-21-8
-
Formula Weight385.397
-
Molecular FormulaC21H16FN7
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC[C@H](NC1=C2N=CNC2=NC=N1)C3=CC4=CC=C(F)C=C4N=C3C5=NC=CC=C5
-
Chemical Name3-Quinolinemethanamine, 7-fluoro-α-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-, (αS)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cushing TD, et al. J Med Chem. 2015 Jan 8;58(1):480-511.
molnova catalog
related products
-
Idelalisib (b)
Idelalisib is a selective inhibitor of p110δ(IC50 : 2.5 nM; in cell-free assays); shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
-
VPS34 inhibitor 1 (C...
VPS34 inhibitor 1 (Compound 19 PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM).
-
IHMT-PI3Kδ-372
IHMT-PI3Kδ-372 is a selective inhibitor of PI3Kδ with an IC50 of 14 nM and can be used in studies about chronic obstructive pulmonary disease.
